How are energy investors positioned?
NeueHealth, Inc. (NASDAQ:NEUE) Chief Financial Officer Jay Matushak recently reported the sale of company stock worth approximately $16,892, according to a filing with the Securities and Exchange Commission. The transaction comes as the stock has experienced an 8.6% decline over the past week, though it maintains a strong 25.8% gain over the last six months. According to InvestingPro analysis, the stock currently appears undervalued relative to its Fair Value. The transactions, which took place on March 11 and March 12, involved the sale of 814 shares at prices ranging from $6.83 to $6.90 per share, and 1,633 shares at prices between $6.71 and $6.98 per share. With the company’s next earnings report scheduled for March 20, investors following this insider activity can access additional insights through InvestingPro, which offers 12 more exclusive tips about NEUE’s financial health and market position.
In addition to these sales, Matushak exercised options to acquire 24,000 shares of common stock on March 12, although this transaction did not involve any cash exchange. Following these transactions, Matushak’s direct ownership in NeueHealth stands at 46,040 shares.
The sales of the shares were undertaken to cover tax withholding obligations upon the vesting of restricted stock units, as noted in the filing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.